/ULIHF

ULIHF Stock - The United Laboratories International Holdings Limited

Q: What is the analyst price target for ULIHF?

Analyst price target information is not currently available for ULIHF.

Q: What is ULIHF's market cap?

Market capitalization information is not currently available for ULIHF.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$1.88+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $2.06

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for ULIHF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.12

52W High$2.35

52W Low$1.25

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$13.76B	$13.74B	$11.33B	$9.70B	$8.77B
Gross Profit	$6.08B	$6.33B	$4.97B	$4.21B	$3.81B
Gross Margin	44.2%	46.1%	43.8%	43.4%	43.4%
Operating Income	$3.12B	$3.29B	$2.02B	$1.41B	$1.23B
Net Income	$2.66B	$2.70B	$1.58B	$988.10M	$702.99M
Net Margin	19.3%	19.7%	13.9%	10.2%	8.0%
EPS	$1.46	$1.49	$0.87	$0.54	$0.40

Company Overview

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.

Visit Website

Earnings History & Surprises

ULIHF

Beat Rate

58%

Last 12 quarters

Avg Surprise

+14.2%

EPS vs Estimate

Beats / Misses

7/5

Last 12 quarters

Latest EPS

$0.15

Q3 2025

EPS Surprise History

Q1 23

+85.7%

$0.08vs$0.04

Q2 23

+102.2%

$0.10vs$0.05

Q4 23

No data

Q1 24

+6.9%

$0.11vs$0.10

Q3 24

+8.0%

$0.11vs$0.10

Q4 24

No data

Q1 25

-17.9%

$0.09vs$0.11

Q3 25

-21.7%

$0.15vs$0.19

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2026	Mar 23, 2026	—	—	—	—
Q3 2025	Sep 1, 2025	$0.19	$0.15	-21.7%	✗ MISS
Q1 2025	Mar 24, 2025	$0.11	$0.09	-17.9%	✗ MISS
Q4 2024	Dec 31, 2024	—	$0.09	—	—
Q3 2024	Aug 29, 2024	$0.10	$0.11	+8.0%	✓ BEAT
Q1 2024	Mar 26, 2024	$0.10	$0.11	+6.9%	✓ BEAT
Q4 2023	Dec 31, 2023	—	$0.11	—	—
Q2 2023	Jun 30, 2023	$0.05	$0.10	+102.2%	✓ BEAT
Q1 2023	Mar 20, 2023	$0.04	$0.08	+85.7%	✓ BEAT
Q4 2022	Dec 31, 2022	—	$0.08	—	—
Q2 2022	Jun 30, 2022	$0.04	$0.05	+23.4%	✓ BEAT
Q1 2022	Mar 22, 2022	$0.05	$0.04	-16.6%	✗ MISS
Q4 2021	Dec 31, 2021	—	$0.03	—	—
Q2 2021	Jun 30, 2021	$0.04	$0.05	+30.1%	✓ BEAT
Q1 2021	Mar 30, 2021	$0.05	$0.04	-3.3%	✗ MISS
Q4 2020	Dec 31, 2020	—	$0.04	—	—
Q2 2020	Jun 30, 2020	$0.03	$0.02	-50.0%	✗ MISS
Q1 2020	Mar 29, 2020	$0.02	$0.03	+23.5%	✓ BEAT
Q4 2019	Dec 31, 2019	—	$0.03	—	—
Q2 2019	Jun 30, 2019	—	$0.03	—	—

Frequently Asked Questions about ULIHF

What is ULIHF's current stock price?

The United Laboratories International Holdings Limited (ULIHF) is currently trading at $1.88 per share. The stock has moved +0.00% today.

What is the analyst price target for ULIHF?

No analyst price targets are currently available for this stock.

What sector is The United Laboratories International Holdings Limited in?

The United Laboratories International Holdings Limited operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is ULIHF's market cap?

The United Laboratories International Holdings Limited has a market capitalization of $3.70 billion, making it a mid-cap company.

Does ULIHF pay dividends?

No, The United Laboratories International Holdings Limited does not currently pay a dividend to shareholders.